These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 38453786)

  • 41. [Drug therapy of acne].
    Ochsendorf FR; Degitz K
    Hautarzt; 2008 Jul; 59(7):579-89; quiz 590. PubMed ID: 18535811
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transdermal penetration of topical drugs used in the treatment of acne.
    Krautheim A; Gollnick H
    Clin Pharmacokinet; 2003; 42(14):1287-304. PubMed ID: 14606932
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical inquiries. What is the best treatment for mild to moderate acne?
    Rao S; Malik MA; Wilder L; Mott T
    J Fam Pract; 2006 Nov; 55(11):994-6. PubMed ID: 17090362
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adverse effects of acne medications: recognition and management.
    Oudenhoven MD; Kinney MA; McShane DB; Burkhart CN; Morrell DS
    Am J Clin Dermatol; 2015 Aug; 16(4):231-242. PubMed ID: 25896771
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Management of truncal acne vulgaris: current perspectives on treatment.
    Del Rosso JQ
    Cutis; 2006 May; 77(5):285-9. PubMed ID: 16776282
    [TBL] [Abstract][Full Text] [Related]  

  • 46. How patients experience and manage dryness and irritation from acne treatment.
    Feldman SR; Chen DM
    J Drugs Dermatol; 2011 Jun; 10(6):605-8. PubMed ID: 21637901
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Topical 5% benzoyl peroxide and 3% erythromycin gel: experience with 191 patients with papulopustular acne.
    Rallis E; Verros C; Katoulis A; Katsarou A
    Acta Dermatovenerol Croat; 2013; 21(3):160-7. PubMed ID: 24183219
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Topical antibacterial therapy for acne vulgaris.
    Dreno B
    Drugs; 2004; 64(21):2389-97. PubMed ID: 15481998
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Topical Vehicle Formulations in the Treatment of Acne.
    Hoffman LK; Bhatia N; Zeichner J; Kircik LH
    J Drugs Dermatol; 2018 Jun; 17(6):s6-s10. PubMed ID: 29879262
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evidence-based topical treatments (azelaic acid, salicylic acid, nicotinamide, sulfur, zinc, and fruit acid) for acne: an abridged version of a Cochrane systematic review.
    Liu H; Yu H; Xia J; Liu L; Liu G; Sang H; Peinemann F
    J Evid Based Med; 2020 Nov; 13(4):275-283. PubMed ID: 33034949
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antibiotic resistance and acne: where we stand and what the future holds.
    Bowe WP
    J Drugs Dermatol; 2014 Jun; 13(6):s66-70. PubMed ID: 24918574
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Combination therapy with retinaldehyde (0.1%) glycolic acid (6%) and efectiose (0.1%) in mild to moderate acne vulgaris during the period of sun exposure--efficacy and skin tolerability.
    Masini F; Ricci F; Fossati B; Frascione P; Capizzi R; De Waure C; Guerriero C
    Eur Rev Med Pharmacol Sci; 2014 Aug; 18(16):2283-6. PubMed ID: 25219827
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tretinoin/benzoyl peroxide cream (Twyneo) for acne.
    Med Lett Drugs Ther; 2022 May; 64(1650):75-76. PubMed ID: 35536121
    [No Abstract]   [Full Text] [Related]  

  • 54. Systemic exposure to benzoic acid and hippuric acid following topical application of clindamycin 1%/benzoyl peroxide 3% fixed-dose combination gel in Japanese patients with acne vulgaris.
    Ino H; Takahashi N; Saenz AA; Wakamatsu A; Hashimoto H; Nakahara N; Hasegawa S
    Clin Pharmacol Drug Dev; 2015 Jan; 4(1):18-24. PubMed ID: 27128000
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fitzpatrick skin types and clindamycin phosphate 1.2%/benzoyl peroxide gel: efficacy and tolerability of treatment in moderate to severe acne.
    Callender VD
    J Drugs Dermatol; 2012 May; 11(5):643-8. PubMed ID: 22527435
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Topical tazarotene: The BEST (balancing efficacy, speed, and tolerability) in acne trial.
    Shalita A
    Cutis; 2004 Oct; 74(4 Suppl):4-8. PubMed ID: 15543713
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adapalene 0.1%/benzoyl peroxide 2.5% gel: a review of its use in the treatment of acne vulgaris in patients aged ≥ 12 years.
    Keating GM
    Am J Clin Dermatol; 2011 Dec; 12(6):407-20. PubMed ID: 21967116
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Optimizing topical combination therapy for the treatment of acne vulgaris.
    Zeichner JA
    J Drugs Dermatol; 2012 Mar; 11(3):313-7. PubMed ID: 22395581
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Randomised controlled multiple treatment comparison to provide a cost-effectiveness rationale for the selection of antimicrobial therapy in acne.
    Ozolins M; Eady EA; Avery A; Cunliffe WJ; O'Neill C; Simpson NB; Williams HC
    Health Technol Assess; 2005 Jan; 9(1):iii-212. PubMed ID: 15588555
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combining clindamycin 1%-benzoyl peroxide 5% gel with multiple therapeutic options.
    Bikowski J; Callender VD; Del Rosso JQ; Draelos ZD; Tanghetti E
    Cutis; 2006 Aug; 78(2 Suppl 1):13-20. PubMed ID: 17966495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.